Pharsight® Events Archive - Seminars
The Parsimonious Path to an IND: Pitfalls and Challenges in Bridging from Preclinical to Phase I
September 4 , 2008
Hyatt Regency San Francisco Airport
Burlingame, California
Presentations
Key Decision-Making Strategies in Preclinical Drug Development
Mark LJ Reimer, Ph.D.
Senior Director, Preclinical Development, Pharsight Reporting and Analysis Services
View Presentation (sign-in required) 
®
Benchmarking Early-Phase HIV and HCV Drug Performance with Literature and In Vitro Data
Bill Poland, Ph.D.
Vice President and Lead Scientist, Pharsight Strategic Consulting Services
View Presentation (sign-in required)
Preclinical Case Study: Population PK Analysis in Juvenile Rats
Mark LJ Reimer, Ph.D.
Senior Director, Preclinical Development, Pharsight Reporting and Analysis Services
View Presentation (sign-in required)
Pharsight PK Accelerator: Software for Efficiently Managing the
Preclinical-Phase I Bridge
Sean P. Mullen
Director, Business Development, Pharsight
View Presentation (sign-in required)